Abstract
Infectious diseases have been evolving and re-evolving over the ages and causing immense misery to humans. Among them, some have been prevented and eradicated, but few are still threatening the modern era since their origin. The majority of these infectious diseases are poverty-driven, hence highly prevalent in the lower-income and mid-income countries of Africa and Asia. The world’s deadliest infections, including Tuberculosis, Malaria and HIV/AIDS, have been considered as the “Big Three” infectious diseases (BTIDs). With leading infections and deaths every year, the BTIDs have been recognized as the world’s greatest pandemics. In light of these alarming situations, this review has been aimed to provide a comprehensive overview of the current status of chemotherapeutics, associated challenges and future perspectives of BTIDs.
Keywords: “Big Three” infectious diseases, Tuberculosis, Malaria, HIV/AIDS, Chemotherapeutic agents, BTIDs, burden.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:“Big Three” Infectious Diseases: Tuberculosis, Malaria and HIV/AIDS
Volume: 21 Issue: 31
Author(s): Parameshwar Makam*Ramkishore Matsa
Affiliation:
- Chemical Science Research Group, Advanced Research Group, Division of Research and Development, Lovely Professional University, Phagwara, Punjab-144411,India
Keywords: “Big Three” infectious diseases, Tuberculosis, Malaria, HIV/AIDS, Chemotherapeutic agents, BTIDs, burden.
Abstract: Infectious diseases have been evolving and re-evolving over the ages and causing immense misery to humans. Among them, some have been prevented and eradicated, but few are still threatening the modern era since their origin. The majority of these infectious diseases are poverty-driven, hence highly prevalent in the lower-income and mid-income countries of Africa and Asia. The world’s deadliest infections, including Tuberculosis, Malaria and HIV/AIDS, have been considered as the “Big Three” infectious diseases (BTIDs). With leading infections and deaths every year, the BTIDs have been recognized as the world’s greatest pandemics. In light of these alarming situations, this review has been aimed to provide a comprehensive overview of the current status of chemotherapeutics, associated challenges and future perspectives of BTIDs.
Export Options
About this article
Cite this article as:
Makam Parameshwar *, Matsa Ramkishore, “Big Three” Infectious Diseases: Tuberculosis, Malaria and HIV/AIDS, Current Topics in Medicinal Chemistry 2021; 21 (31) . https://dx.doi.org/10.2174/1568026621666210916170417
DOI https://dx.doi.org/10.2174/1568026621666210916170417 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Self-assembled Antibiotic Nanoparticles Against Intracellular Bacteria
Drug Delivery Letters Clinical Interpretation of Drug Susceptibility Tests in Tuberculosis
Current Respiratory Medicine Reviews A Novel Functional Approach Toward Identifying Definitive Drug Targets
Current Medicinal Chemistry Renal Phosphate Handling in Antiretroviral-naive HIV-Infected Patients
Infectious Disorders - Drug Targets New Insights into Lipidic Secondary Metabolites in Mycobacteria
Current Chemical Biology Guinea Pig Model of Infectious Disease - Viral Infections
Current Drug Targets New Strategies and Paradigm for Drug Target Discovery: A Special Focus on Infectious Diseases Tuberculosis, Malaria, Leishmaniasis, Trypanosomiasis and Gastritis
Infectious Disorders - Drug Targets Adolescents Attitudes Toward Vaccinations: A Systematic Review
Current Pediatric Reviews The Synthetic Potential and Chemical Aspects of the Gewald Reaction: Application in the Preparation of 2-Aminothiophenes and Related Heterocycles
Current Organic Synthesis Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent
Anti-Cancer Agents in Medicinal Chemistry KEMREP: A New Qualitative Method for the Assessment of an Analyst’s Ability to Generate a Metabolomics Data Matrix by Gas Chromatography– Mass Spectrometry
Current Metabolomics Understanding Recognition and Self-assembly in Biology using the Chemist´s Toolbox. Insight into Medicinal Chemistry
Current Topics in Medicinal Chemistry Review of Methods and Various Catalysts Used for Chalcone Synthesis
Mini-Reviews in Organic Chemistry NMDA Pathology and Treatment of Schizophrenia
Current Pharmaceutical Design Pharmacophore and Docking Based Virtual Screening of Validated Mycobacterium tuberculosis Targets
Combinatorial Chemistry & High Throughput Screening Editorial [Hot Topic: New Developments in Drug and Vaccine Discoveries (Executive Editor: Aldar S. Bourinbaiar)]
Current Pharmaceutical Design Antimicrobial Activities of 1-H-Benzimidazole-based Molecules
Current Topics in Medicinal Chemistry Drug Repurposing: Translational Pharmacology, Chemistry, Computers and the Clinic
Current Topics in Medicinal Chemistry Microbial Biotransformation: Recent Developments on Steroid Drugs
Recent Patents on Biotechnology Design, Synthesis and Computational Studies of New Benzothiazole Substituted Quinazolines as Potential Antimicrobial Agents
Letters in Drug Design & Discovery